New Policy for Ambetter
Effective March 31, 2022: Clinical Policies
Superior HealthPlan has updated certain clinical policies to ensure medical necessity to review criteria is current and appropriate for members and the scope of services provided. As a result, the following policies are effective on March 31, 2022 at 12 AM.
Policy
Hospice
Applicable Products - Ambetter
Policy updates include:
Revised forced vital capacity (FVC) in II.B.3.a from < 40% to < 30%
Revised II.F.b.3 from, “>33% lean body mass,” to, “loss of at least 10% lean body mass”
Nerve Blocks and Neurolysis for Pain Management
Applicable Products - Medicaid, Ambetter
Policy updates include:
Revised policy title from “Nerve Blocks for Pain Management” to “Nerve Blocks and Neurolysis for Pain Management”
Added VII. Insufficient evidence to determine the safety and effectiveness of intraosseous radiofrequency nerve ablation of basivertebral nerve.